American Academy of Dermatology

Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.

Immune checkpoint inhibitor therapy does not appear to increase complication rates in patients undergoing dermatologic procedures, according to a video oral abstract presentation at the 2022 ASDS Annual Meeting.

Allergic contact dermatitis and atopic dermatitis are common causes of rashes in the pediatric population. Patch testing can help demystify the cause of such skin conditions and determine treatment.

The results from the Evelo Biosciences EDP1815 treatment provide the first demonstration in a phase 2 trial of the safety and efficacy of an orally-administered, gut-restricted SINTAX medicine.

LEO Pharma presented long-term data from an interim analysis of its ECZTEND 5-year extension trial, showing no new safety signals.

What are the best post- and pre-lightening products and strategies for optimal results on all skin types? Renata Block, president of the Society of Dermatology Physician Assistants, walked through her pearls in this interview at the American Academy of Dermatology 2022 Annual Meeting.

Renata Block, MMS, PA-C, president of the Society of Dermatology Physician Assistants (PAs) talked with Dermatology Times® at the American Academy of Dermatology 2022 Annual Meeting about the broadening opportunities for these advanced health care providers to help fill the demand gap for treatment of skin and hair disorders as well as aesthetic services.

A poster from the 2022 American Academy of Dermatology Annual Meeting gathered the real-world data around patients using dupilumab to treat atopic dermatitis.

A poster from the 2022 American Academy of Dermatology Annual Meeting presented subgroup analyses from the Effisayil 1 study that showed the efficacy of spesolimab was consistent across all prespecified patient populations, including those with or without IL-36RN mutations.

VisualDX uses diverse imagery to help increase knowledge of disease manifestations in a range of skin types.

In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

Medications, plants, and more may play a significant role in systemic contact dermatitis.

In this second part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the data behind the clinical trials on using circulating tumor DNA for merkel cell carcinoma (MCC). She expands on her talk from the 2022 American Academy of Dermatology Annual Meeting.

The company announced its collaboration with the American Academy of Dermatology on, “Pathways: Inclusivity in Dermatology,” to increase the number of practicing dermatologists in the Black, Latino, and Indigenous communities in medicine over the next 5 years.

The company’s combined the need for science advancement with a booth that kept people coming back.

Klint Peebles, MD, FAAD, breaks down the core terminology for LGBTQ/SGD individuals so all patients can feel understood when entering the exam room.

In a presentation at the recent AAD annual meeting, Diane M. Thiboutot, MD, discusses the potential risks of antibiotic resistance in acne management.

What’s new in body skin care? According to Neil Sadick, MD, FACP, FAACS, FACph, FAAD, all fingers point to these methods.

In his presentation at the recent AAD, Neil Sadick, MD, FACP, FAACS, FACph, FAAD, highlighted new cosmeceutical concepts for the body, including the whole-body rejuvenation program and AM/PM approach.

Christopher Bunick, MD, PhD, offered pointers on how to address the physical and mental aspects of this complex disease in this exclusive interview in conjunction with the American Academy of Dermatology 2022 Annual Meeting.

In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.

Social media can be a great way to expand exposure for a practice or physician; however, there are many dos-and-don’ts to understand when signing up for a social platform.

In her presentation at the recent American Academy of Dermatology (AAD) Annual Meeting, Anisha Patel, MD, FAAD, discusses challenging oncodermatology cases at the MD Anderson Cancer Center, University of Texas Health Science Center.

Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.

In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.

New data shows complete skin clearance using bimekizumab in moderate to severe plaque psoriasis open-label extension study.

Clascoterone cream 1% phase 3 results presented at meeting.

Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.